[Experimental cholesterin atherosclerosis in the rabbit: action of a duodenal heparinoid. III. Modifications in the factors of hemocoagulation, plasmin and plasminogen, and in the thromboplastin and fibrinolytic activity of the aortic wall].
D000818:Animals; D001011:Aorta / Q000378:metabolism*; D001161:Arteriosclerosis; D050197:Atherosclerosis; D001777:Blood Coagulation / Q000494:pharmacology*; D002784:Cholesterol / Q000494:pharmacology*; D005341:Fibrinolysin; D006493:Heparin / Q000031:analogs & derivatives; D006496:Heparinoids; D010958:Plasminogen; D011817:Rabbits; D015912:Thrombolytic Therapy; D013925:Thromboplastin
D006496:Heparinoids; D010958:Plasminogen; D006493:Heparin; D013925:Thromboplastin; D002784:Cholesterol; D005341:Fibrinolysin
AORTA/metabolism; ARTERIOSCLEROSIS/experimental; BLOOD COAGULATION/pharmacology; CHOLESTEROL/pharmacology; HEPARIN/related compounds